Fat gram target to achieve high energy intake in cystic fibrosis

被引:9
作者
Collins, CE
OLoughlin, EV
Henry, RL
机构
[1] Department of Paediatrics, John Hunter Children's Hospital, New Lambton Heights, NSW
[2] Department of Gastroenterology, New Children's Hospital, Westmead, NSW
[3] Department of Paediatrics, University of Newcastle, Callaghan, NSW
[4] Dept. of Nutrition and Dietetics, John Hunter Hospital, Hunter Region Mail Centre, NSW 2310
关键词
cystic fibrosis; diet; nutrition;
D O I
10.1111/j.1440-1754.1997.tb01017.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: Higher fat and energy intakes confer a survival advantage in cystic fibrosis (CF). There is a need to develop effective nutrition programmes that ensure optimal energy intake in CF. Methodology: A cross-sectional measurement of clinical characteristics and energy and fat intakes in patients attending the CF outpatients clinic of the John Hunter Hospital, Newcastle was undertaken. Twenty-nine subjects, mean age 12 years (range 4.3-20.2), completed weighed food records to determine the contribution of fat to the percentage of the recommended energy intake obtained and to document use of pancreatic enzyme replacement therapy, Results: Diets with a high percentage of energy derived from fat did not guarantee that individuals with CF met their energy requirements. Subjects with total fat intakes of 100 g per day or greater, however, achieved in excess of 110% recommended daily intake (RDI) for energy. Up to 47% of subjects consumed more pancreatic enzyme replacement capsules than shown to give maximum effectiveness. Conclusion: Setting a 100 g daily fat target is a realistic way of ensuring high energy intakes in CF. Fat ready reckoners would identify the fat content of food and prescribe specific numbers of pancreatic enzyme replacement capsules to be consumed with each meal or food item.
引用
收藏
页码:142 / 147
页数:6
相关论文
共 26 条
  • [1] [Anonymous], HUMAN GROWTH
  • [2] MEASUREMENTS OF TOTAL-ENERGY EXPENDITURE PROVIDE INSIGHTS INTO THE VALIDITY OF DIETARY MEASUREMENTS OF ENERGY-INTAKE
    BLACK, AE
    PRENTICE, AM
    GOLDBERG, GR
    JEBB, SA
    BINGHAM, SA
    LIVINGSTONE, MBE
    COWARD, WA
    [J]. JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1993, 93 (05) : 572 - 579
  • [3] USE OF PANCREATIC-ENZYME SUPPLEMENTS FOR PATIENTS WITH CYSTIC-FIBROSIS IN THE CONTEXT OF FIBROSING COLONOPATHY
    BOROWITZ, DS
    GRAND, RJ
    DURIE, PR
    BEKER, LT
    DODGE, JA
    FINK, RJ
    FITZSIMMONS, SC
    FREIMAN, J
    KALNINS, D
    KIMURA, R
    KIRSCHNER, B
    LLOYDSTILL, JD
    LOWENFELS, A
    MAGUINESS, K
    ROBERTS, IM
    SCHWARZENBERG, SJ
    SMYTH, RL
    STEVENS, JC
    STONE, RT
    THOMPSON, B
    VANVELZEN, D
    WEST, K
    ZERIN, JM
    [J]. JOURNAL OF PEDIATRICS, 1995, 127 (05) : 681 - 684
  • [4] CONSTANTINI D, 1988, J PEDIAT GASTROEN S1, V7, P36
  • [5] A COMPARISON OF SURVIVAL, GROWTH, AND PULMONARY-FUNCTION IN PATIENTS WITH CYSTIC-FIBROSIS IN BOSTON AND TORONTO
    COREY, M
    MCLAUGHLIN, FJ
    WILLIAMS, M
    LEVISON, H
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (06) : 583 - 591
  • [6] COMPARISON OF THE MACRONUTRIENT INTAKE OF HEALTHY CONTROLS AND CHILDREN WITH CYSTIC-FIBROSIS ON LOW FAT OR NONRESTRICTED FAT DIETS
    DANIELS, L
    DAVIDSON, GP
    MARTIN, AJ
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1987, 6 (03) : 381 - 386
  • [7] DANIELS LA, 1989, AUST PAEDIATR J, V25, P261
  • [8] DANIELS LA, 1984, HUM NUTR-APPL NUTR, V83, pA110
  • [9] NUTRITION
    DURIE, PR
    PENCHARZ, PB
    [J]. BRITISH MEDICAL BULLETIN, 1992, 48 (04) : 823 - 847
  • [10] THE CHANGING EPIDEMIOLOGY OF CYSTIC-FIBROSIS
    FITZSIMMONS, SC
    [J]. JOURNAL OF PEDIATRICS, 1993, 122 (01) : 1 - 9